Mannatech Launches Ūth Advanced Skin Matrix Rejuvenation Crème

  Mannatech Launches Ūth Advanced Skin Matrix Rejuvenation Crème

      New Skin Care Based on Mannatech’s Pioneering Work in Glycobiology

Business Wire

COPPELL, Texas -- November 12, 2013

Mannatech®, Incorporated (NASDAQ: MTEX), the founder of the Mission 5
Million^SM social entrepreneurial movement and leading innovator of
naturally-sourced supplements based on Real Food Technology^® solutions,
launched Ū^th Advanced Skin Matrix Rejuvenation Crème, a revolutionary new
skin care product based on their pioneering work in the science of

Ū^th, pronounced “youth,” symbolizes ageless beauty whose time has come. The
official launch of the skin care product took place at Mannatech’s M5M℠
Leadership Experience event in Frisco, Texas on November 9^th, 2013. From
November 1-7, the product was available for pre-order sales and pre-sales
exceeded management expectations. Ū^th will be available to the public for
purchase later this week on

Ū^th Skin Rejuvenation Crème releases your body’s natural ability to support
beautiful, healthy skin through a new, patented microsphere delivery system
that nourishes your skin with youth-inducing ingredients in a time-released
pattern. This pattern optimizes the natural production of skin cells at all
levels by delivering naturally sourced, complex sugars called glycans found in
Manapol powder. The science of glycobiology is uncovering the way our bodies
work at the cellular level. New research in this field has unlocked the
knowledge of why our skin loses youthfulness as we age, and more importantly,
how glycans provide the network that allows cells to communicate and spark our
skin’s natural ability to strengthen itself. The science of glycobiology has
decoded the secrets to healthier, younger-looking skin. Those discoveries are
now available in Mannatech’s new product, Ū^th.

Mannatech’s research and development team worked closely with internationally
renowned dermatologist, Dr. Martin Kassir, to develop Mannatech'sŪ^thSkin
Rejuvenation Crème. Dr. Kassir utilized his extensive experience and research
to mastermind the formulation in combination with Mannatech’s advanced
glyconutrient technology. Dr. Kassir is double-board certified in both
dermatology and internal medicine and specializes in cosmetic dermatology and
laser procedures. His dermatology practice, in Dallas and New York City,
caters to national and international clientele.Dr. Kassir has a B.A. from
University of Texas at Austin; an M.D. from UT Southwestern Medical Center in
Dallas; and residencies from UT Southwestern Medical Center (internal
medicine), and Kansas University Medical Center (dermatology), Kansas City.
Learn more about Ū^th with these videos: Ū^th Skin Rejuvenation Crème by
Mannatech and The Story of Ū^th – Dr. Martin Kassir.

For more information on Mannatech’s products, or to explore its business
opportunity, visit

About Mannatech

Mannatech, Incorporated, develops high-quality health, weight and fitness, and
skin care products that are based on the solid foundation of nutritional
science and development standards. Mannatech is dedicated to its platform of
Social Entrepreneurship based on the foundation of promoting, aiding and
optimizing nutrition where it is needed most around the world. Mannatech’s
proprietary products are available through independent sales Associates around
the globe including the United States, Canada, South Africa, Australia, New
Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the
United Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of
Ireland, Czech Republic, the Republic of Korea, Mexico, Namibia, Hong Kong and
Ukraine. For more information, visit

Please note: This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E
of the Securities Exchange Act of 1934, as amended, and the Private Securities
Litigation Reform Act of 1995. These forward-looking statements generally can
be identified by use of phrases or terminology such as “believe,” “intend” or
other similar words or the negative of such terminology. Similarly,
descriptions of Mannatech’s objectives, strategies, plans, goals or targets
contained herein are also considered forward-looking statements. Mannatech
believes this release should be read in conjunction with all of its filings
with the United States Securities and Exchange Commission and cautions its
readers that these forward-looking statements are subject to certain events,
risks, uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain Associates and Members,
increases in competition, litigation, regulatory changes and its planned
growth into new international markets. Although Mannatech believes that the
expectations, statements and assumptions reflected in these forward-looking
statements are reasonable, it cautions readers to always consider all of the
risk factors and any other cautionary statements carefully in evaluating each
forward-looking statement in this release, as well as those set forth in its
latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other
filings filed with the United States Securities and Exchange Commission,
including its current reports on Form 8-K. All of the forward-looking
statements contained herein speak only as of the date of this release.


Mannatech, Incorporated
Brett Duncan, 972-471-7367
Press spacebar to pause and continue. Press esc to stop.